We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Higher Mortality for Hyperglycemic Stroke Patients

By HospiMedica staff writers
Posted on 25 Jul 2002
A study has shown that stroke patients with high blood sugar at the time of hospital admission have a higher risk of death than stroke patients with normal blood sugar. More...
The study was published in the July 9, 2002, issue of Neurology.

Researchers at the Indiana University School of Medicine (IU, Indianapolis, USA) analyzed the medical records of 656 stroke patients. More than 40% had high blood sugar. Although most had a previous diagnosis of diabetes, their blood sugar was not under control. The researchers found that having high blood sugar when stroke occurred put patients at risk for higher 30-day, one-year, and five-year mortality than patients with normal blood sugar.

The stroke patients with high blood sugar also stayed longer in the hospital and had higher hospital costs. Another finding was that during hospitalization, the hyperglycemia of patients was not treated adequately, with more than 90% of these patients continuing to have high blood sugar during their hospital stay.

"Diabetes is a growing problem in the United States. With the link shown in our study between diabetes and poor outcome after stroke, hyperglycemia at the time of stroke may become an even greater problem in years ahead, both in terms of deaths and medical costs,” said Linda S. Williams, M.D., assistant professor of neurology at IU and principal investigator. The same researchers are planning to conduct a phase II study of rapid normalization of high blood sugar at the time of stroke, a treatment available at any hospital.

IU >> www.medicine.iu.edu



Related Links:
Indiana University School of Medicine

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.